GlobeVerge
Home / business
WORLD
Soriot should explain the curious case of AstraZeneca’s non-deal
AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholders AstraZeneca falls to third-largest UK company amid US merger talks Hold the heartburn pills. It seems AstraZeneca is no longer contemplating a takeover of US rival Bris
GlobeSignal
World Watch
Developments like this can have effects beyond the immediate story.
Expand ▾
More in General
GlobeSignal: A transparent, keyword-based read on this story's tone and stakes—not financial, political or safety advice. The summary above is the original publisher's excerpt, not AI-generated or rewritten by GlobeVerge. Open the original source link before acting on any story.